Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. Vol. 76, Journal of the American College of Cardiology. Elsevier Inc.; 2020. p. 2982–3021.
Nelson S, Whitsel L, Khavjou O, Phelps D, Leib A. Projections of cardiovascular disease prevalence and costs. RTI Int, Res Triangle Park NC, USA, Tech Rep. 2016;214680(001.001).
Sjögren B, Bigert C, Gustavsson P. Chapter 16 - Cardiovascular Disease. In: Nordberg GF, Fowler BA, Nordberg MBT-H on the T of M (Fourth E, editors. San Diego: Academic Press; 2015. p. 313–31. Available from: https://www.sciencedirect.com/science/article/pii/B9780444594532000160
World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. Geneva: World Health Organization press; 2007.
Otgontuya D, Oum S, Palam E, Rani M, Buckley BS. Individual-based primary prevention of cardiovascular disease in Cambodia and Mongolia: early identification and management of hypertension and diabetes mellitus. BMC Public Health. 2012;12(1):254. [cited 2021 Feb 8]. Available from: (http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-254).
Article
Google Scholar
Palmieri L, Bennett K, Giampaoll S, Capewell S. Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health. 2010;100(4):684–92 pmc/articles/PMC2836342/?report=abstract.
Article
Google Scholar
Ofori SN, Odia OJ. Risk assessment in the prevention of cardiovascular disease in low-resource settings. Indian Heart J. 2016;68(3):391–8.
Article
Google Scholar
Richards A, Cheng EM. Stroke risk calculators in the era of electronic health records linked to administrative databases. Vol. 44, Stroke. 2013 [cited 2021 Jun 7]. p. 564–9. Available from: http://stroke.ahajournals.org
Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol. 1976;38(1):46–51.
Article
CAS
Google Scholar
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study. Br Med J. 2007;335(7611):136–41.
Article
Google Scholar
Ministry of Health Brunei Darussalam. Brunei Darussalam National Multi-Sectoral Action Plan for the Prevention and Control of Non-Communicable Diseases - 2013 | ICCP Portal [Internet]. [cited 2021 Feb 7]. Available from: https://www.iccp-portal.org/brunei-darussalam-national-multi-sectoral-action-plan-prevention-and-control-non-communicable
WHO. Country Fact Sheet Public Health Data at a Glance. Brunei Darussalam [Internet]. [cited 2021 Jun 3]. Available from: https://www.who.int/docs/default-source/wpro---documents/countries/brunei-darussalam/fact-sheet-brunei-darussalam.pdf?sfvrsn=b91eddf4_5
Ministry of Health Brunei Darussalam. BruHealth. A one-stop mobile application for anything COVID-19 related in Brunei Darussalam. [Internet]. Ministry of Health - bruhealth. [cited 2022Jun11]. Available from: http://www.moh.gov.bn/SitePages/bruhealth.aspx
Bitton A, Gaziano T. The Framingham Heart Study’s Impact on Global Risk Assessment. Prog Cardiovasc Dis. 2010;53(1):68–78.
Article
Google Scholar
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representat. Eur Heart J. 2016;37(29):2315–81.
Article
Google Scholar
Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American college of cardiology/American heart association task force on practice guidelines [Internet]. Vol. 129, Circulation. Lippincott Williams and Wilkins; 2014 [cited 2021 Feb 8]. p. 49–73. Available from: http://circ.ahajournals.org/lookup/suppl/doi:https://doi.org/10.1161/01.cir.0000437741.48606.98/-/DC1.
Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: A prospective open cohort study. BMJ. 2010;340(7758):1231. [cited 2021 Feb 8]. Available from: (https://www.qresearch.org/).
Google Scholar
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2. BMJ. 2008;336(7659):1475–82.
Article
Google Scholar
Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: Assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens. 2007;25(8):1578–82.
Article
CAS
Google Scholar
Parmar P, Krishnamurthi R, Ikram MA, Hofman A, Mirza SS, Varakin Y, et al. The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke. 2014/12/10. 2015;10(2):231–44. Available from: https://pubmed.ncbi.nlm.nih.gov/25491651
Hasabullah M, Kahtani F, Balkhoyor T, Al-Harbi L, Kinsara AJ. A Comparison of Four Cardiovascular Risk Assessment Instruments in Saudi Patients. Cureus. 2020;12(Cvd):2–9.
Google Scholar
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Vol. 169, Annals of Internal Medicine. American College of Physicians; 2018. p. 467–73.
Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305–10.
Article
CAS
Google Scholar
Beswick AD, Brindle P, Fahey T, Ebrahim S. A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement). London; 2008.
Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study. BMJ. 2009;339(7713):144–7. [cited 2021 Feb 11]. Available from: (https://www.thin-uk.com).
Google Scholar
Mendis S, Lindholm LH, Anderson SG, Alwan A, Koju R, Onwubere BJC, et al. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings. J Clin Epidemiol. 2011;64(12):1451–62. [cited 2021 Feb 21]Available from: (https://pubmed.ncbi.nlm.nih.gov/21530172/).
Article
Google Scholar
Siontis GC, Tzoulaki I, Siontis KC, Ioannidis JP. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ. 2012;344.
Kariuki JK, Stuart-Shor EM, Leveille SG, Hayman LL. Evaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithms. BMC Cardiovasc Disord. 2013;13(1):1–3.
Otgontuya D, Oum S, Buckley BS, Bonita R. Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia. BMC Public Health. 2013;13(1):1–2.
Bansal M, Kasliwal RR, Trehan N. Comparative accuracy of different risk scores in assessing cardiovascular risk in Indians: A study in patients with first myocardial infarction. Indian Heart J. 2014;66(6):580–6. Available from: https://doi.org/10.1016/j.ihj.2014.10.399.
Article
PubMed
PubMed Central
Google Scholar
Selvarajah S, Kaur G, Haniff J, Cheong KC, Hiong TG, Van Der Graaf Y, et al. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population. Int J Cardiol. 2014;176(1):211–8. Available from: https://doi.org/10.1016/j.ijcard.2014.07.066.
Article
PubMed
Google Scholar
Ofori S, Dodiyi-Manuel S, Akpa MR. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease. J Clin Lipidol. 2017;11(6):1441–7. Available from: https://doi.org/10.1016/j.jacl.2017.09.004.
Article
PubMed
Google Scholar
Bonner C, Fajardo MA, Hui S, Stubbs R, Trevena L. Clinical validity, understandability, and actionability of online cardiovascular disease risk calculators: systematic review. J Med Internet Res. 2018;20(2):e8538.
Kaptoge S, Pennells L, De Bacquer D, Cooney MT, Kavousi M, Stevens G, et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Heal. 2019;7(10):e1332–45.
Article
Google Scholar
Hosein A, Stoute V, Chadee S, Singh NR. Evaluating Cardiovascular Disease (CVD) risk scores for participants with known CVD and non-CVD in a multiracial/ethnic Caribbean sample. Palazón-Bru A, editor. PeerJ. 2020;8:e8232. Available from: https://doi.org/10.7717/peerj.8232.
Article
CAS
PubMed
PubMed Central
Google Scholar
Studziński K, Tomasik T, Krzysztoń J, Jóźwiak J, Windak A. Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews. BMC Cardiovasc Disord. 2019;19(1):1–6.
Ezzati M, Vander Hoorn S, Rodgers A, Lopez AD, Mathers CD, Murray CJL. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet. 2003;362(9380):271–80. [cited 2021 Feb 9]. Available from: https://pubmed.ncbi.nlm.nih.gov/12892956/
Collins GS, Altman DG. an Independent Validation of Qrisk on the Thin Database. 2015;(January). Available from: https://www.bcs.com/documents/Z47_Collins_Altman_QRISK.pdf
Riley V, Ellis NJ, Cowap L, Grogan S, Cottrell E, Crone D, Chambers R, Clark-Carter D, Fedorowicz S, Gidlow C. A qualitative exploration of two risk calculators using video-recorded NHS health check consultations. BMC Fam Pract. 2020;21(1):1–3.
Article
Google Scholar
International Society of Hypertension. WHO / ISH Risk prediction charts for 14 WHO epidemiological sub-regions. 2007;1–39. Available from: http://ish-world.com/downloads/activities/colour_charts_24_Aug_07.pdf
Islam JY, Zaman MM, Moniruzzaman M, Shakoor SA, Hossain AE. Estimation of total cardiovascular risk using the 2019 WHO CVD prediction charts and comparison of population-level costs based on alternative drug therapy guidelines: a population-based study of adults in Bangladesh. BMJ Open. 2020;10(7):e035842.
Findlay SG, Kasliwal RR, Bansal M, Tarique A, Zaman A. A comparison of cardiovascular risk scores in native and migrant South Asian populations. SSM - Popul Heal. 2020;11:100594. Available from: https://www.sciencedirect.com/science/article/pii/S2352827320302317
Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. [cited 2021 Feb 9]; Available from: http://www.bmj.com/
Tulloch-Reid MK, Younger NO, Ferguson TS, Francis DK, Abdulkadri AO, Gordon-Strachan GM, et al. Excess Cardiovascular Risk Burden in Jamaican Women Does Not Influence Predicted 10-Year CVD Risk Profiles of Jamaica Adults: An Analysis of the 2007/08 Jamaica Health and Lifestyle Survey. Barengo NC, editor. PLoS One. 2013;8(6):e66625. [cited 2021 Feb 10]. Available from: (https://dx.plos.org/10.1371/journal.pone.0066625).
Article
CAS
Google Scholar
Nordet PR, Mendis S, Dueñas A, De La Noval R, Armas N, De La Noval IL, et al. Total cardiovascular risk assessment and management using two prediction tools, with and without blood cholesterol. MEDICC Rev. 2013;15(4):36–40.
PubMed
Google Scholar
Mendis S, Lindholm LH, Anderson SG, Alwan A, Koju R, Onwubere BJC, et al. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings. J Clin Epidemiol. 2011;64(12):1451–62. [cited 2021 Feb 7]. Available from: (https://pubmed.ncbi.nlm.nih.gov/21530172/)
Article
Google Scholar
Board JBS. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100(Suppl 2):ii1-67.
Article
Google Scholar
Crossan C, Lord J, Ryan R, Nherera L, Marshall T. Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study. Br J Gen Pract. 2017;67(654):e67 LP-e77. Available from: (http://bjgp.org/content/67/654/e67.abstract).
Article
Google Scholar
Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104(23):2855–64. [cited 2021 Feb 9]. Available from: (https://pubmed.ncbi.nlm.nih.gov/11733407/).
Article
CAS
Google Scholar
Barzi F, Patel A, Gu D, Sritara P, Lam TH, Rodgers A, et al. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health. 2007;61(2):115–21. [cited 2021 Feb 9]. Available from: (https://pubmed.ncbi.nlm.nih.gov/17234869/).
Article
CAS
Google Scholar
Liu J, Hong Y, D’Agostino RB, Wu Z, Wang W, Sun J, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-provincial Cohort Study. J Am Med Assoc. 2004;291(21):2591–9. [cited 2021 Feb 9]. Available from: (https://pubmed.ncbi.nlm.nih.gov/15173150/).
Article
CAS
Google Scholar
Tonkin AM, Lim SS, Schirmer H. Cardiovascular risk factors: When should we treat? [Internet]. Vol. 178, Medical Journal of Australia. Australasian Medical Publishing Co. Ltd; 2003 [cited 2021 Feb 9]. p. 101–2. Available from: https://pubmed.ncbi.nlm.nih.gov/12558473/
Chiew SSL, Tuah NAA, Lai ASC, Yazdi A, Majeed A, Wint Z. Prevalence of cardiovascular disease risk factors with stratification of tenyear total cardiovascular risk among the working adults in Brunei Darussalam. Brunei Int Med J. 2017;13(5):148–56.
Google Scholar
World Health Organization. Global status report on noncommunicable diseases 2014, “Attaining the nine global noncommunicable diseases targets; a shared responsibility.” Geneva: World Health Organization press; 2014.